Your browser doesn't support javascript.
loading
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade.
Pang, Kun; Shi, Zhen-Duo; Wei, Liu-Ya; Dong, Yang; Ma, Yu-Yang; Wang, Wei; Wang, Guang-Yue; Cao, Ming-Yang; Dong, Jia-Jun; Chen, Yu-Ang; Zhang, Peng; Hao, Lin; Xu, Hao; Pan, Deng; Chen, Zhe-Sheng; Han, Cong-Hui.
Afiliação
  • Pang K; Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, 199 Jiefang South Road, Xuzhou, Jiangsu, China; School of Life Sciences, Jiangsu Normal University, Jiangsu, China.
  • Shi ZD; Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, 199 Jiefang South Road, Xuzhou, Jiangsu, China; School of Life Sciences, Jiangsu Normal University, Jiangsu, China; Department of Urology, Heilongjiang Provincial Hospital, Heilongjiang, China.
  • Wei LY; School of Pharmacy, Weifang Medical University, Weifang, Shandong 261053, China.
  • Dong Y; Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, 199 Jiefang South Road, Xuzhou, Jiangsu, China.
  • Ma YY; Graduate School, Bengbu Medical College, Building 1, Administration Building, 2600 Donghai Avenue, Bengbu, Anhui, China.
  • Wang W; Department of Medical College, Southeast University, 87 DingjiaQiao, Nanjing, China.
  • Wang GY; Graduate School, Bengbu Medical College, Building 1, Administration Building, 2600 Donghai Avenue, Bengbu, Anhui, China.
  • Cao MY; Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, 199 Jiefang South Road, Xuzhou, Jiangsu, China.
  • Dong JJ; School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang 212013, Jiangsu Province, China.
  • Chen YA; Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, 199 Jiefang South Road, Xuzhou, Jiangsu, China.
  • Zhang P; Graduate School, Bengbu Medical College, Building 1, Administration Building, 2600 Donghai Avenue, Bengbu, Anhui, China.
  • Hao L; Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, 199 Jiefang South Road, Xuzhou, Jiangsu, China.
  • Xu H; Graduate School, Bengbu Medical College, Building 1, Administration Building, 2600 Donghai Avenue, Bengbu, Anhui, China.
  • Pan D; Graduate School, Bengbu Medical College, Building 1, Administration Building, 2600 Donghai Avenue, Bengbu, Anhui, China.
  • Chen ZS; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, USA. Electronic address: chenz@stjohns.edu.
  • Han CH; Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, 199 Jiefang South Road, Xuzhou, Jiangsu, China; School of Life Sciences, Jiangsu Normal University, Jiangsu, China; Department of Urology, Heilongjiang Provincial Hospital, Heilongjiang, China. Elect
Drug Resist Updat ; 66: 100907, 2023 01.
Article em En | MEDLINE | ID: mdl-36527888
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Receptor de Morte Celular Programada 1 / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Receptor de Morte Celular Programada 1 / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article